ADA Presidents' Select Abstract: Effects of Tirzepatide vs. Insulin Glargine 100 U/mL on Kidney Outcomes in Participants with Type 2 Diabetes in SURPASS-4

被引：2
|
作者：
Heerspink, Hiddo L.
Sattar, Naveed
Pavo, Imre
Haupt, Axel
Duffin, Kevin L.
Yang, Zhengyu
Wiese, Russell
Tuttle, Katherine R.
Cherney, David
机构：
来源：
DIABETES | 2022年 / 71卷
关键词：
D O I：
10.2337/db22-17-OR
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
17-OR
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Comparative effectiveness of Glargine 300 U/mL vs. Degludec 100 U/mL in patients with type 2 diabetes switching from 1? generation basal insulins
    Buzzetti, Raffaella
    Fadini, Gian Paolo
    Nicolucci, Antonio
    Larosa, Monica
    Rossi, Maria Chiara
    Cucinotta, Domenico
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2022, 32 (09) : 2255 - 2263
  • [32] Real-World Health Outcomes of Insulin Glargine 300 U/mL (Gla-300) vs. Insulin Glargine 100 U/mL (Gla-100) in Patients with Type 1 (T1D) and Type 2 Diabetes (T2D) in the Canadian LMC Diabetes Patient Registry-The REALITY Study
    Abitbol, Alexander
    Brown, Ruth E.
    Jiandani, Dishay
    Sauriol, Luc
    Aronson, Ronnie
    DIABETES, 2018, 67
  • [33] Lower pharmacokinetic and pharmacodynamic within-day variability of individual clinical doses of insulin glargine 300 U/ml vs glargine 100 U/ml in type 1 diabetes
    Fanelli, C. G.
    Lucidi, P.
    Candeloro, P.
    Cioli, P.
    Andreoli, A. Marinelli
    Bolli, G. B.
    Porcellati, F.
    DIABETOLOGIA, 2018, 61 : S409 - S409
  • [34] Similar glycaemic control and less or comparable hypoglycaemia with insulin glargine 300 U/ml vs degludec 100 U/ml in insulin naive type 2 diabetes: the BRIGHT randomised study
    Cheng, A.
    Rosenstock, J.
    Ritzel, R.
    Bosnyak, Z.
    Devisme, C.
    Stella, P.
    Cali, A. M. G.
    Wang, X.
    Frias, J.
    Roussel, R.
    Bolli, G. B.
    DIABETOLOGIA, 2018, 61 : S42 - S42
  • [35] Cost-Effectiveness of Insulin Degludec vs. Insulin Glargine U100 in Type 1 and Type 2 Diabetes Mellitus in a UK Setting
    Marc Evans
    Roopa Mehta
    Jens Gundgaard
    Barrie Chubb
    Diabetes Therapy, 2018, 9 : 1919 - 1930
  • [36] Cost-Effectiveness of Insulin Degludec vs. Insulin Glargine U100 in Type 1 and Type 2 Diabetes Mellitus in a UK Setting
    Evans, Marc
    Mehta, Roopa
    Gundgaard, Jens
    Chubb, Barrie
    DIABETES THERAPY, 2018, 9 (05) : 1919 - 1930
  • [37] Use of Insulin Glargine 100 U/mL for the Treatment of Type 2 Diabetes Mellitus in East Asians: A Review
    Takahisa Hirose
    Ching-Chu Chen
    Kyu Jeung Ahn
    Jacek Kiljański
    Diabetes Therapy, 2019, 10 : 805 - 833
  • [38] COST MINIMIZATION ANALYSIS OF INSULIN GLARGINE 300 U/ML VS GLARGINE 100 U/ML FOR THE MANAGEMENT OF TYPE 2 DIABETES FROM A PRIVATE AND PUBLIC THIRD-PARTY PAYER PERSPECTIVE IN CHILE
    Russo, M.
    Bitran, R.
    Rodriguez, J. C.
    Grassi, B.
    Aguilera, P.
    VALUE IN HEALTH, 2018, 21 : S75 - S75
  • [39] Comparative clinical efficacy and safety of insulin glargine 300 U/ml (Toujeo) versus insulin glargine 100 U/ml in type 2 diabetes and type 1 diabetes: A systematic literature review and meta-analysis
    Joshi, Shashank R.
    Singh, Gursharan
    Marwah, Ashwani
    Mittra, Shivani
    Suvarna, Viraj R.
    Athalye, Sandeep N.
    DIABETES OBESITY & METABOLISM, 2023, 25 (06): : 1589 - 1606
  • [40] Comparative effectiveness of insulin glargine 300 U/mL and insulin degludec 100 U/mL in insulin naive type 2 diabetes adults: the Restore-2 naive cohort
    Fadini, G. P.
    Buzzetti, R.
    Larosa, M.
    Rossi, M. C.
    Nicolucci, A.
    Cucinotta, D.
    DIABETOLOGIA, 2021, 64 (SUPPL 1) : 74 - 74
12345